Literature DB >> 23413880

Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme.

Jinzhe Mao1, Mathias Schmelcher, William J Harty, Juli Foster-Frey, David M Donovan.   

Abstract

Peptidoglycan hydrolases are an effective new source of antimicrobials. A chimeric fusion protein of the Ply187 endopeptidase domain and LysK SH3b cell wall-binding domain is a potent agent against Staphylococcus aureus in four functional assays.
© 2013 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23413880      PMCID: PMC3690576          DOI: 10.1111/1574-6968.12104

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  23 in total

1.  The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus.

Authors:  S O'Flaherty; A Coffey; W Meaney; G F Fitzgerald; R P Ross
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

Review 2.  Bacteriophage endolysins--current state of research and applications.

Authors:  Martin J Loessner
Journal:  Curr Opin Microbiol       Date:  2005-08       Impact factor: 7.934

3.  Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes.

Authors:  E Díaz; R López; J L García
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 4.  The pneumococcal cell wall degrading enzymes: a modular design to create new lysins?

Authors:  R López; E García; P García; J L García
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

5.  Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus.

Authors:  T Baba; O Schneewind
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

6.  Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits.

Authors:  E Diaz; R López; J L Garcia
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

7.  Evidence for a holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187.

Authors:  M J Loessner; S Gaeng; S Scherer
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

Review 8.  Bacteriophage lytic enzymes: novel anti-infectives.

Authors:  Vincent A Fischetti
Journal:  Trends Microbiol       Date:  2005-10       Impact factor: 17.079

9.  Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling.

Authors:  M M Sheehan; J L García; R López; P García
Journal:  FEMS Microbiol Lett       Date:  1996-06-15       Impact factor: 2.742

10.  Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme.

Authors:  C Croux; C Ronda; R López; J L García
Journal:  Mol Microbiol       Date:  1993-09       Impact factor: 3.501

View more
  35 in total

1.  Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.

Authors:  Carolin T Verbree; Steven M Dätwyler; Susanne Meile; Fritz Eichenseher; David M Donovan; Martin J Loessner; Mathias Schmelcher
Journal:  Appl Environ Microbiol       Date:  2017-03-17       Impact factor: 4.792

Review 2.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

3.  Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.

Authors:  Yanling Huang; Hang Yang; Junping Yu; Hongping Wei
Journal:  Virol Sin       Date:  2015-02-04       Impact factor: 4.327

4.  Role of SH3b binding domain in a natural deletion mutant of Kayvirus endolysin LysF1 with a broad range of lytic activity.

Authors:  Martin Benešík; Jiří Nováček; Lubomír Janda; Radka Dopitová; Markéta Pernisová; Kateřina Melková; Lenka Tišáková; Jiří Doškař; Lukáš Žídek; Jan Hejátko; Roman Pantůček
Journal:  Virus Genes       Date:  2017-08-29       Impact factor: 2.332

5.  Corrected and Republished from: Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.

Authors:  Carolin T Verbree; Steven M Dätwyler; Susanne Meile; Fritz Eichenseher; David M Donovan; Martin J Loessner; Mathias Schmelcher
Journal:  Appl Environ Microbiol       Date:  2017-12-15       Impact factor: 4.792

6.  Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.

Authors:  Daniel C Osipovitch; Sophie Therrien; Karl E Griswold
Journal:  Appl Microbiol Biotechnol       Date:  2015-02-18       Impact factor: 4.813

Review 7.  Therapeutics and delivery vehicles for local treatment of osteomyelitis.

Authors:  Leah H Cobb; Emily M McCabe; Lauren B Priddy
Journal:  J Orthop Res       Date:  2020-04-21       Impact factor: 3.494

8.  Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.

Authors:  Pawan Kumar Singh; David M Donovan; Ashok Kumar
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

Review 9.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

10.  Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo.

Authors:  Hang Yang; Yun Zhang; Junping Yu; Yanling Huang; Xian-En Zhang; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.